CD4 and lung cancer: In particular, functional subtypes within the CD8+PD-1+ T-cell compartment are thought to predict responses to PD-1 blockade in lung cancer, while CD4+ PD-1+ T cells have been reported as non-responders to PD-1 blockade in malignant melanoma (31, 32).